Bellevue Group Ag Bio Rad Laboratories, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 46,151 shares of BIO stock, worth $16.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

46,151

Previous 155,258 70.27%

Holding current value

$16.7 Million

Previous $42.4 Million 63.58%

% of portfolio

0.26%

Previous 0.71%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $28.8 Million - $37.6 Million	-109,107 Reduced 70.27%	46,151 $15.4 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $364,833 - $461,692	-1,360 Reduced 0.87%	155,258 $42.4 Million
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $4.7 Million - $5.45 Million	15,471 Added 10.96%	156,618 $54.2 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $1.84 Million - $2.49 Million	6,817 Added 5.07%	141,147 $45.6 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $71,100 - $85,793	-203 Reduced 0.15%	134,330 $48.2 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $7.48 Million - $10.1 Million	20,794 Added 18.28%	134,533 $51 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $1.08 Million - $1.3 Million	2,581 Added 2.32%	113,739 $54.5 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $3.28 Million - $4.26 Million	9,340 Added 9.17%	111,158 $46.8 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $4.4 Million - $6 Million	10,657 Added 11.69%	101,818 $42.5 Million
Q2 2022 Aug 11, 2022	BUY	$463.67 - $597.16 $8.88 Million - $11.4 Million	19,152 Added 26.6%	91,161 $45.1 Million
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $17 Million - $23.8 Million	32,326 Added 81.46%	72,009 $40.6 Million
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $4.49 Million - $5.03 Million	-6,332 Reduced 13.76%	39,683 $30 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $27.2 Million - $34.1 Million	-41,286 Reduced 47.29%	46,015 $34.3 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $7.44 Million - $8.37 Million	-12,901 Reduced 12.87%	87,301 $56.2 Million
Q1 2021 May 12, 2021	BUY	$547.01 - $662.35 $19.6 Million - $23.7 Million	35,797 Added 55.58%	100,202 $57.2 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $7.04 Million - $8.87 Million	-13,781 Reduced 17.63%	64,405 $37.5 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $765,714 - $902,486	-1,685 Reduced 2.11%	78,186 $40.3 Million
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $5.86 Million - $8.63 Million	17,498 Added 28.05%	79,871 $36.1 Million
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $4.99 Million - $6.38 Million	15,588 Added 33.32%	62,373 $21.9 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $12.8 Million - $15 Million	40,035 Added 593.11%	46,785 $17.3 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $2.06 Million - $2.33 Million	6,750 New	6,750 $2.25 Million

Others Institutions Holding BIO

# of Institutions

455

Shares Held

17.7M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Bio Rad Laboratories, Inc. Transaction History